FOXP3 and type 1 diabetes mellitus: Another study confirmed the absence of active FoxP3+ Tregs in the small intestine and demonstrated that LP-derived DCs of T1D patients were not even capable of inducing FoxP3+ Tregs in vitro possibly leading to an over-activated mucosal immunity within T1D (31).